(Q33696585)

28 July 2017

title

Fatigue in fibromyalgia: a conceptual model informed by patient interviews (English)

1 reference

28 July 2017

0 references

1 reference

Bente Danneskiold-Samsøe

5

object named as

Bente Danneskiold Samsoe

1 reference

28 July 2017

Louise Humphrey

1

1 reference

28 July 2017

Rob Arbuckle

2

1 reference

28 July 2017

Philip Mease

3

1 reference

28 July 2017

David A Williams

4

1 reference

28 July 2017

Claire Gilbert

6

1 reference

28 July 2017

publication date

20 September 2010

1 reference

BMC Musculoskeletal Disorders

28 July 2017

published in

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

page(s)

216

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

start time

20 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Patient perspectives on the impact of fibromyalgia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Patient-reported outcomes to support medical product labeling claims: FDA perspective

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Distinguishing fatigue and depression in patients with cancer.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Gender differences in fibromyalgia and other related syndromes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Ten rural women living with fibromyalgia tell it like it is.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

The burden of musculoskeletal diseases in the general population of Spain: results from a national survey

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Classification, epidemiology, and natural history of fibromyalgia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

A phenomenological study of fibromyalgia. Patient perspectives

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

The prevalence and meaning of fatigue in rheumatic disease.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

The prevalence and characteristics of fibromyalgia in the general population.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946273

Prevalence of fibromyalgia: a survey in five European countries

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

Individuals' descriptions of living with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

The lived experience of fibromyalgia in African American women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

The experience of living with fibromyalgia: confronting an invisible disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

Perspectives on patient-reported outcomes : content validity and qualitative research in a changing clinical trial environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

How Many Interviews Are Enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-216

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

21 January 2018

1 reference

12 December 2020

Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study

1 reference

12 December 2020

Fibromyalgia syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Histological abnormalities in muscle from patients with certain types of fibrositis

1 reference

12 December 2020

[Rheumatism epidemiology in Europe]

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2474-11-216

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-11-216

9 September 2019

1 reference

28 July 2017

1 reference